Wolverine Trading
TXMD icon

Wolverine Trading’s TherapeuticsMD TXMD Stock Holding History

Wolverine Trading’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-31,100
Closed -$309K – 5371
2022
Q2 		$309K Buy
+31,100
New +$297K ﹤0.01% 3049
2022
Q1 		– Sell
-1,862
Closed -$34K – 6474
2021
Q4 		$34K Buy
1,862
+194
+12% +$5.81K ﹤0.01% 5421
2021
Q3 		$61K Buy
1,668
+636
+62% +$28.2K ﹤0.01% 5975
2021
Q2 		$61K Sell
1,032
-344
-25% -$20.8K ﹤0.01% 5561
2021
Q1 		$92K Buy
+1,376
New +$108K ﹤0.01% 5472
2020
Q4 		– Sell
-592
Closed -$48K – 5498
2020
Q3 		$48K Buy
592
+268
+83% +$21.4K ﹤0.01% 4282
2020
Q2 		$19K Sell
324
-1,366
-81% -$79.5K ﹤0.01% 4443
2020
Q1 		$90K Buy
1,690
+842
+99% +$83.5K ﹤0.01% 4065
2019
Q4 		$101K Sell
848
-476
-36% -$68.4K ﹤0.01% 4275
2019
Q3 		$250K Buy
+1,324
New +$187K ﹤0.01% 3347
2019
Q2 		– Sell
-570
Closed -$139K – 5154
2019
Q1 		$139K Sell
570
-300
-34% -$79.4K ﹤0.01% 4023
2018
Q4 		$171K Sell
870
-1,184
-58% -$289K ﹤0.01% 3784
2018
Q3 		$674K Buy
2,054
+818
+66% +$251K ﹤0.01% 2762
2018
Q2 		$301K Hold
1,236
– – ﹤0.01% 3773
2018
Q1 		$301K Buy
1,236
+464
+60% +$130K ﹤0.01% 3773
2017
Q4 		$233K Buy
+772
New +$215K ﹤0.01% 3954

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Wolverine Trading's TXMD Position: Q3 2021 in Review

Wolverine Trading sold out of TherapeuticsMD (TXMD) in Q3 2021, closing a stake of 461 shares — an estimated $20.5K sold.

Wolverine Trading first reported a position in TXMD in Q4 2017 and held it in 13 quarters. The position peaked at $370K in Q3 2018. 149 funds tracked by Wall St. Rank hold TXMD as of Q3 2021.

  • Wolverine Trading reported no remaining TherapeuticsMD position as of Q3 2021 after selling out during the quarter.
  • Wolverine Trading sold 461 TherapeuticsMD shares in Q3 2021, an estimated $20.5K.
  • Wolverine Trading first reported a position in TherapeuticsMD in Q4 2017 and held it in 13 quarters.
  • Wolverine Trading's TherapeuticsMD position peaked at $370K in Q3 2018.
  • 149 funds tracked by Wall St. Rank held TherapeuticsMD as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.